Expression of PD-L1 Molecule in Hypopharyngeal and Nasopharyngeal Carcinomas
Background: Head and neck cancer has the third highest prevalence rate among tumors internationally, with significant rates of mortality and recurrence. The pathway of Programmed Cell Death Protein-1 (PD-1)/ Programmed Cell Death Ligand-1 (PD-L1) is essential in the mechanisms of tumor immune evasio...
| Published in: | SVU - International Journal of Medical Sciences |
|---|---|
| Main Authors: | Ahmed Roshdi Hamed Ahmed, Nagwa Abd El-Sadek Ahmed, Nahawand Mohamed Hafez Elnakib, Rasha Mokhtar Abdelkareem |
| Format: | Article |
| Language: | English |
| Published: |
South Valley University, Faculty of Medicine
2025-01-01
|
| Subjects: | |
| Online Access: | https://svuijm.journals.ekb.eg/article_425662.html |
Similar Items
Mechanisms of Resistance to Chemotherapy in Hypopharyngeal Carcinoma
by: Zhaoyue Lu, et al.
Published: (2025-10-01)
by: Zhaoyue Lu, et al.
Published: (2025-10-01)
Reconstruction of Hypopharynx and Cervical Oesophagus for Treatment of Advanced Hypopharyngeal Carcinoma and Recurrent Laryngeal Carcinoma
by: Qing Xiao
Published: (2010-01-01)
by: Qing Xiao
Published: (2010-01-01)
Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma
by: Wen Gao, et al.
Published: (2024-10-01)
by: Wen Gao, et al.
Published: (2024-10-01)
PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes
by: Qi Fang, et al.
Published: (2024-05-01)
by: Qi Fang, et al.
Published: (2024-05-01)
The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
by: Zi-Lu Huang, et al.
Published: (2019-05-01)
by: Zi-Lu Huang, et al.
Published: (2019-05-01)
Anlotinib suppressed tumor cell proliferation and migration in hypopharyngeal carcinoma
by: Hao Song, et al.
Published: (2024-03-01)
by: Hao Song, et al.
Published: (2024-03-01)
Familial clustering of nasopharyngeal carcinoma in the family of an adolescent with nasopharyngeal carcinoma
by: Buket Kara, et al.
Published: (2022-12-01)
by: Buket Kara, et al.
Published: (2022-12-01)
PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma
by: Feng Jiang, et al.
Published: (2019-05-01)
by: Feng Jiang, et al.
Published: (2019-05-01)
Development and validation of a diagnostic model for predicting cervical lymph node metastasis in laryngeal and hypopharyngeal carcinoma
by: Xingdong Wu, et al.
Published: (2024-04-01)
by: Xingdong Wu, et al.
Published: (2024-04-01)
Efficacy of PD-1 inhibitor with neoadjuvant chemotherapy in hypopharyngeal and oropharyngeal cancer
by: Xue-Ying Liu, et al.
Published: (2024-09-01)
by: Xue-Ying Liu, et al.
Published: (2024-09-01)
Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
by: Kina Kase, et al.
Published: (2021-03-01)
by: Kina Kase, et al.
Published: (2021-03-01)
The clinical outcomes of induction chemotherapy followed by radiotherapy vs. chemoradiotherapy in locally advanced hypopharyngeal squamous cell carcinoma: A retrospective study
by: Ke Jiang, et al.
Published: (2024-10-01)
by: Ke Jiang, et al.
Published: (2024-10-01)
PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients
by: Christoph Minichsdorfer, et al.
Published: (2019-11-01)
by: Christoph Minichsdorfer, et al.
Published: (2019-11-01)
EFNA2 Mediates Stiffness-Regulated Hypopharyngeal Cancer Progression
by: Songqun Hu, et al.
Published: (2025-05-01)
by: Songqun Hu, et al.
Published: (2025-05-01)
ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner
by: Juan Hu, et al.
Published: (2023-11-01)
by: Juan Hu, et al.
Published: (2023-11-01)
Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages
by: Xiaofei Yuan, et al.
Published: (2025-05-01)
by: Xiaofei Yuan, et al.
Published: (2025-05-01)
Thyroid Dysfunction After Intensity-Modulated Radiotherapy and PD⁃1 Inhibitor Treatment for Locally Advanced Nasopharyngeal Carcinoma
by: Shang K, et al.
Published: (2025-01-01)
by: Shang K, et al.
Published: (2025-01-01)
Short-course PD-1 blockade in locally advanced nasopharyngeal carcinoma: a phase II randomized trial protocol (Tori-013)
by: Hongyuan Jia, et al.
Published: (2025-08-01)
by: Hongyuan Jia, et al.
Published: (2025-08-01)
Reversine Induces Apoptosis of FaDu Hypopharyngeal Carcinoma Cells
by: Seo Yun Jung
Published: (2024-12-01)
by: Seo Yun Jung
Published: (2024-12-01)
Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov
by: Zelei Dai, et al.
Published: (2023-11-01)
by: Zelei Dai, et al.
Published: (2023-11-01)
Hypopharyngeal Squamous Cell Carcinoma in Elderly Patients Aged ≥70 Years: Surgery and Postoperative Radiotherapy Improves Outcomes in Selected Patients
by: Wang R, et al.
Published: (2025-07-01)
by: Wang R, et al.
Published: (2025-07-01)
Prognostic value of α2δ1 in hypopharyngeal carcinoma: A retrospective study
by: Liu Qiang, et al.
Published: (2021-09-01)
by: Liu Qiang, et al.
Published: (2021-09-01)
Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review
by: Le Yan, et al.
Published: (2023-01-01)
by: Le Yan, et al.
Published: (2023-01-01)
Progress on Multi-disciplinary Combined Therapy for Locally Advanced Hypopharyngeal Carcinoma
by: LUO Xi, et al.
Published: (2023-04-01)
by: LUO Xi, et al.
Published: (2023-04-01)
Use of camrelizumab in treatment of nasopharyngeal carcinoma
by: Yu. V. Alymov, et al.
Published: (2024-12-01)
by: Yu. V. Alymov, et al.
Published: (2024-12-01)
Prognostic Factors and Long-Term Outcome Prediction in Patients with Hypopharyngeal Carcinoma Treated with (Chemo)radiotherapy: Development of a Prognostic Model
by: Miloslav Pala, et al.
Published: (2025-02-01)
by: Miloslav Pala, et al.
Published: (2025-02-01)
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyResearch in context
by: Xi Ding, et al.
Published: (2023-07-01)
by: Xi Ding, et al.
Published: (2023-07-01)
Survival and long-term quality-of-life of concurrent chemoradiotherapy versus surgery followed by radiotherapy with or without concurrent chemotherapy for the treatment of resectable stage III/IV hypopharyngeal carcinoma
by: Zehao Huang, et al.
Published: (2023-09-01)
by: Zehao Huang, et al.
Published: (2023-09-01)
Tumour microbiota structure predicts hypopharyngeal carcinoma recurrence and metastasis
by: Xiaohui Yuan, et al.
Published: (2023-12-01)
by: Xiaohui Yuan, et al.
Published: (2023-12-01)
CeRNA network reveals potential diagnostic biomarkers or immunotherapy targets for Hypopharyngeal squamous cell carcinoma
by: Xi Yang, et al.
Published: (2025-09-01)
by: Xi Yang, et al.
Published: (2025-09-01)
Cerebral Radionecrosis in Patients with Nasopharyngeal Carcinoma
by: Ying-Che Hsu, et al.
Published: (2005-10-01)
by: Ying-Che Hsu, et al.
Published: (2005-10-01)
Evaluating the influence of anti-PD-1 immunotherapy combined with IMRT on thyroid dysfunction in nasopharyngeal carcinoma
by: Liqianqi Chen, et al.
Published: (2025-01-01)
by: Liqianqi Chen, et al.
Published: (2025-01-01)
Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
by: Hongjia Liu, et al.
Published: (2023-03-01)
by: Hongjia Liu, et al.
Published: (2023-03-01)
Efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase 2 trial
by: Yaofei Jiang, et al.
Published: (2025-03-01)
by: Yaofei Jiang, et al.
Published: (2025-03-01)
Surgically-Treated Locoregionally Advanced Hypopharyngeal Cancer: Outcomes
by: Jorge Rodrigues, et al.
Published: (2018-07-01)
by: Jorge Rodrigues, et al.
Published: (2018-07-01)
An MRI-based radiomics nomogram for detecting cervical esophagus invasion in hypopharyngeal squamous cell carcinoma
by: Meng Qi, et al.
Published: (2023-12-01)
by: Meng Qi, et al.
Published: (2023-12-01)
The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma
by: Xiaoyong Xiang, et al.
Published: (2023-04-01)
by: Xiaoyong Xiang, et al.
Published: (2023-04-01)
Prevalence of HPV infection in hypopharyngeal and laryngeal squamous cell carcinoma at Thailand's largest tertiary referral center
by: Warut Pongsapich, et al.
Published: (2017-11-01)
by: Warut Pongsapich, et al.
Published: (2017-11-01)
Screening of co-expressed genes in hypopharyngeal carcinoma with esophageal carcinoma based on RNA sequencing and Clinical Research
by: Jianing Zhang, et al.
Published: (2024-06-01)
by: Jianing Zhang, et al.
Published: (2024-06-01)
Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors
by: Jianming Diao, et al.
Published: (2025-03-01)
by: Jianming Diao, et al.
Published: (2025-03-01)
Similar Items
-
Mechanisms of Resistance to Chemotherapy in Hypopharyngeal Carcinoma
by: Zhaoyue Lu, et al.
Published: (2025-10-01) -
Reconstruction of Hypopharynx and Cervical Oesophagus for Treatment of Advanced Hypopharyngeal Carcinoma and Recurrent Laryngeal Carcinoma
by: Qing Xiao
Published: (2010-01-01) -
Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma
by: Wen Gao, et al.
Published: (2024-10-01) -
PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes
by: Qi Fang, et al.
Published: (2024-05-01) -
The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
by: Zi-Lu Huang, et al.
Published: (2019-05-01)
